Acetaldehyde elicits ERK phosphorylation in the rat nucleus accumbens and extended amygdala

Synapse

Volumn 64, Issue 12, 2010, Pages 916-927

  Vinci, Stefania ^a   Ibba, Federico ^a   Longoni, Rosanna ^a   Spina, Liliana ^a   Spiga, Saturnino ^a   Acquas, Elio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

4 methylpyrazole; Acetaldehyde; D penicillamine; Ethanol; PERK; SCH 39166

Indexed keywords

4 METHYLPYRAZOLE; ACETALDEHYDE; ALCOHOL; DOPAMINE 1 RECEPTOR; ECOPIPAM; MITOGEN ACTIVATED PROTEIN KINASE; PENICILLAMINE;

ALCOHOL METABOLISM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CLINICAL EVALUATION; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ACETALDEHYDE; ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; AMYGDALA; ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; NUCLEUS ACCUMBENS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77958166357     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20811     Document Type: Article

References (65)

1. Acquas E, Pisanu A, Spiga S, Plumitallo A, Zernig G, Di Chiara G., 2007., Differential effects of intravenous R, S-(±)-3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) and its S(+)- and R(-)-enantiomers on dopamine transmission and extracellular signal regulated kinase phosphorylation (pERK) in the rat nucleus accumbens shell and core., J Neurochem, 102:, 121-132.
2. Acquas E, Vinci S, Ibba F, Spiga S, De Luca MA, Di Chiara G., 2010., Role of dopamine D1 receptors in caffeine-mediated ERK phosphorylation in the rat brain., Synapse, 64:, 341-349.
3. Amit Z, Brown ZW, Rockman GE., 1977., Possible involvement of acetaldehyde, norepinephrine and their tetrahydroisoquinoline derivatives in the regulation of ethanol self-administration., Drug Alcohol Depend, 2:, 495-500.
4. Arizzi MN, Correa M, Betz AJ, Wisniecki A, Salamone JD., 2003., Behavioral effects of intraventricular injections of low doses of ethanol, acetaldehyde, and acetate in rats: Studies with low and high rate operant schedules., Behav Brain Res, 147:, 203-210.
5. Arizzi-LaFrance M, Correa M, Argon CM, Salamone JD., 2006., Motor stimulant effects of ethanol injected into the substantia nigra pars reticulata: Importance of catalase-mediated metabolism and the role of acetaldehyde., Neuropsychopharmacology, 31:, 997-1008.
6. Arnt J, Hyttel J, Sanchez C., 1992., Partial and full dopamine D1 receptor agonists in mice and rats: Relation between behavioral effects and stimulation of adenylate cyclase activity in vitro., Eur J Pharmacol, 213:, 259-267.
7. Beninger RJ, Gerdjikov T., 2004., The role of signaling molecules in reward-related incentive learning., Neurotoxicity Res, 61:, 91-104.
8. Brown ZW, Amit Z, Rockman GE., 1979., Intraventricular self-administration of acetaldehyde, but not ethanol, in naïve laboratory rats., Psychopharmacology, 64:, 271-276.
9. Brown ZW, Amit Z, Smith BR., 1980., Intraventricular self-administration of acetaldehyde and voluntary consumption of ethanol in rats., Behav Neural Biol, 28:, 150-155.
10. Brown ZW, Amit Z, Smith BR, Sutherland EA, Selvaggi N., 1983., Alcohol-induced euphoria enhanced by disulfiram and calcium carbimide., Alcohol Clin Exp Res, 7:, 276-278.
11. Carboni E, Silvagni A, Rolando MT, Di Chiara G., 2000., Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs., J Neurosci, 20:, RC102.
12. Clemente-Jimenez JM, Mingorance-Cazorla L, Martínez-Rodríguez S, Las Heras-Vázquez FJ, Rodríguez-Vico F., 2005., Influence of sequential yeast mixtures on wine fermentation., Int J Food Microbiol, 98:, 301-308.
13. Correa M, Arizzi MN, Betz A, Mingote S, Salamone JD., 2003., Open field locomotor effects in rats after intraventricular injections of ethanol and the ethanol metabolites acetaldehyde and acetate., Brain Res Bull, 62:, 197-202.
14. Correa M, Manrique HM, Font L, Escrig MA, Aragon CM., 2008., Reduction in the anxiolytic effects of ethanol by centrally formed acetaldehyde: The role of catalase inhibitors and acetaldehyde-sequestering agents., Psychopharmacology, 200:, 455-464.
15. Di Chiara G., 2002., Nucleus accumbens shell and core dopamine: Differential role in behavior and addiction., Eur J Pharmacol, 137:, 75-114.
16. Di Chiara G, Imperato A., 1988., Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats., Proc Natl Acad Sci USA, 85:, 5274-5278.
17. Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu S, Cadoni C, Carboni E., 1999., Drug addiction as a disorder of associative learning: Role of nucleus accumbens shell/extended amygdala dopamine., Ann NY Acad Sci, 877:, 461-485.
18. Enrico P, Sirca D, Mereu M, Peana AT, Lintas A, Golosio A, Diana M., 2009., Acetaldehyde sequestering prevents ethanol-induced stimulation of mesolimbic dopamine transmission., Drug Alcohol Depend, 100:, 265-271.
19. Farin FM, Oniecinski CJ., 1993., Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue., J Toxicol Environ Health, 40:, 317-335.
20. FDA-U.S. Food and Drug Administration., 2008., Code of Federal Regulations, Washington, DC, 21CFR172.515.
21. Foddai M, Dosia G, Spiga S, Diana M., 2004., Acetaldehyde increases dopaminergic neuronal activity in the VTA., Neuropsychopharmacology, 29:, 530-536.
22. Font L, Miquel M, Aragon CM., 2005., Prevention of ethanol-induced behavioral stimulation by D-penicillamine: A sequestration agent for acetaldehyde., Alcoholism: Clin Exp Res, 29:, 1156-1164.
23. Font L, Aragon CM, Miquel M., 2006a., Voluntary ethanol consumption decreases after the inactivation of central acetaldehyde by D-penicillamine., Behav Brain Res, 171:, 78-86.
24. Font L, Aragon CM, Miquel M., 2006b., Ethanol-induced conditioned place preference, but not aversion, is blocked by treatment with D-penicillamine, an inactivation agent for acetaldehyde., Psychopharmacology, 184:, 56-64.
25. Gill K, Menez JF, Lucas D, Deitrich RA., 1992., Enzymatic production of acetaldehyde from ethanol in rat brain tissue., Alcoholism: Clin Exp Res, 16:, 910-915.
26. Girault JA, Valjent E, Caboche J, Herve D., 2007., ERK2: A logical AND gate critical for drug-induced plasticity?, Curr Opin Pharmacol, 7:, 77-85.
27. Holtzman SG, Schnider FH., 1974., Comparison of acetaldehyde and ethanol: Depression of motor activity in mice., Life Sci, 14:, 1243-1250.
28. Ibba F, Vinci S, Spiga S, Peana AT, Assaretti AR, Spina L, Longoni R, Acquas E., 2009., Ethanol-induced extracellular signal regulated kinase: Role of dopamine D1 receptors., Alcoholism: Clin Exp Res, 33:, 858-867.
29. Kapur JN, Sahoo PK, Wong KC., 1985., A new method for gray-level picture thresholding using the entropy of the histogram., Comput Vis Graph Image Process, 29:, 273-285.
30. Kiselevski Y, Oganesian N, Zimatkin S, Szutowicz A, Angielski S, Niezabitowski P, Uracz W, Gryglewski RJ., 2003., Acetate metabolism in brain mechanisms of adaptation to ethanol., Med Sci Monit, 9:, BR178-BR182.
31. Koob GF., 1999., The role of the striatopallidal and extended amygdala systems in drug addiction., Ann NY Acad Sci, 877:, 445-460.
32. Leriche M, Méndez M, Zimmer L, Bérod A., 2008., Acute ethanol induces Fos in GABAergic and non-GABAergic forebrain neurons: A double-labeling study in the medial prefrontal cortex and extended amygdala., Neuroscience, 153:, 259-267.
33. Lieber CS., 2004., The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role., Drug Metab Rev, 36:, 511-529.
34. Lu L, Koya E, Zhai H, Hope BT, Shaham Y., 2006., Role of ERK in cocaine addiction., TiNS, 29:, 695-703.
35. McLaughlin PJ, Chuck TL, Arizzi-LaFrance MN, Salamone JD, Correa M., 2008., Central vs. peripheral administration of ethanol, acetaldehyde and acetate in rats: Effects on lever pressing and response initiation., Pharmacol Biochem Behav, 89:, 304-313.
36. McQuade RD, Duffy RA, Anderson CC, Crosby G, Coffin VL, Chipkin RE, Barnett A., 1991., [3H]SCH 39166, a new D1-selective radioligand: In vitro and in vivo binding analyses., J Neurochem, 57:, 2001-2010.
37. Medicamenta., 1991-1992. Vol., 1:, Parte generale: Tab. 18-19., Milano, Italy:, Cooperativa Farmaceutica Milanese. p, 814-815.
38. Melis M, Enrico P, Peana AT, Diana M., 2007., Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system., Eur J Neurosci, 26:, 2824-2833.
39. Miyake T, Shibamoto T., 1993., Quantitative analysis of acetaldehyde in foods and beverages., J Agric Food Chem, 41:, 1968-1970.
40. Nagasawa HT, Elberling JE, Roberts JC., 1987., Beta-substituted cysteines as sequestering agents for ethanol-derived acetaldehyde in vivo., J Med Chem, 30:, 1373-1378.
41. Ortiz A, Griffiths PJ, Littleton JM., 1974., A comparison of the effects of chronic administration of ethanol and acetaldehyde to mice: Evidence for a role of acetaldehyde in ethanol dependence., JPharm Pharmacol, 26:, 249-260.
42. Paxinos G, Watson C., 1998., The rat brain in stereotaxic coordinates., Sydney:, Academic Press.
43. Peana AT, Enrico P, Assaretti AR, Puliche E, Muggironi G, Nieddu M, Piga A, Lintas A, Diana M., 2008., Key role of ethanol-derived acetaldehyde in the motivational properties induced by intragastric ethanol: A conditioned place preference study in the rat., Alcohol Clin Exp Res, 32:, 249-258.
44. Peana AT, Assaretti AR, Muggironi G, Enrico P, Diana M., 2009., Reduction of ethanol-derived acetaldehyde induced motivational properties by L-cysteine., Alcohol Clin Exp Res, 33:, 43-48.
45. Quertemont E, Tambour S., 2004., Is ethanol a pro-drug? The role of acetaldehyde in the central effects of ethanol., Trends Pharmacol Sci, 25:, 130-134.
46. Quertemont E, Tambour S, Bernaerts P, Zimatkin SM, Tirelli E., 2004., Behavioral characterization of acetaldehyde in C57BL/6J mice: Locomotor, hypnotic, anxiolytic and amnesic effects., Psychopharmacology, 177:, 84-92.
47. Quertemont E, Tambour S, Tirelli E., 2005., The role of acetaldehyde in the neurobehavioral effects of ethanol: A comprehensive review of animal studies., Prog Neurobiol, 75:, 247-274.
48. Rodd-Henricks ZA, Melendez RI, Zaffaroni A, Goldstein A, McBride WJ, Lu TK., 2002., The reinforcing effects of acetaldehyde in the posterior ventral tegmental area of alcohol-preferring rats., Pharmacol Biochem Behav, 72:, 55-64.
49. Rodd ZA, Bell RL, Zhang Y, Murphy JM, Goldstein A, Zaffaroni A, Li TK, McBride WJ., 2005., Regional heterogeneity for the intracranial self-administration of ethanol and acetaldehyde within the ventral tegmental area of alcohol-preferring (P) rats: Involvement of dopamine and serotonin., Neuropsychopharmacology, 30:, 330-338.
50. Salzmann J, Marie-Claire C, Le Guen S., Roques BP, Noble F., 2003., Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice., Br J Pharmacol, 140:, 831-828.
51. Seitz HK, Becker P., 2007., Alcohol metabolism and cancer., Alcohol Health Res, 30:, 38-41, 44-47.
52. Soukoulis C, Panagioditis P, Koureli R, Tzia C., 2007., Industrial yogurth manufacture: Monitoring of fermentation process and improvement of final product quality., J Dairy Sci, 90:, 2641-2654.
53. Smith BR, Amit Z, Splawinsky J., 1984., Conditioned place preference induced by intraventricular infusions of acetaldehyde., Alcohol, 1:, 193-195.
54. 1 receptors and extracellular signal regulated kinase in the motivational properties of acetaldehyde as assessed by place preference conditioning., Alcoholism: Clin Exp Res, 34:, 607-616.
55. Suh JJ, Pettinati HM, Kampman KM, O'Brien CP., 2006., The status of disulfiram: A half of a century later., J Clin Psychopharmacol, 26:, 290-302.
56. Sweatt JD., 2004., Mitogen-activated protein kinases in synaptic plasticity and memory., Curr Opin Neurobiol, 14:, 311-317.
57. Talhout R, Opperhuizen A, van Amsterdam JGC., 2007., Role of acetaldehyde in tobacco smoke addiction., Eur Neuropsyhopharmacol, 17:, 627-636.
58. Tambour S, Closon C, Tirelli E, Quertemont E., 2007., Effects of cyanamide and acetaldehyde accumulation on the locomotor stimulant and sedative effects of ethanol in mice., Behav Pharmacol, 18:, 777-784.
59. Valjent E, Corvol JC, Pages C, Besson MJ, Maldonado R, Caboche J., 2000., Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties., J Neurosci, 20:, 8701-8709.
60. Valjent E, Pages C, Rogard M, Besson MJ, Maldonado R, Caboche J., 2001., δ9-Tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission., Eur J Neurosci, 14:, 342-352.
61. Valjent E, Pages C, Herve D, Girault JA, Caboche J., 2004., Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain., Eur J Neurosci, 19:, 1826-1836.
62. Zhai H, Li Y, Wang X, Lu L., 2008., Drug-induced alterations in the extracellular signal-regulated kinase (ERK) signalling pathway: Implications for reinforcement and reinstatement., Cell Mol Neurobiol, 28:, 157-172.
63. Zimatkin SM, Lindros KO., 1996., Distribution of catalase in rat brain: Aminergic neurons as possible targets for ethanol effects., Alcohol Alcohol, 31:, 167-174.
64. Zimatkin SM, Liopo AV, Deitrich RA., 1998., Distribution and kinetics of ethanol methabolism in rat brain., Alcoholism: Clin Exp Res, 22:, 1623-1627.
65. Yoshimoto K, Ueda S, Kato B, Takeuchi Y, Kawai Y, Noritake K, Yasuhara M., 2000., Alcohol enhances characteristic release of dopamine and serotonin in the central nucleus of the amygdala., Neurochem Int, 37:, 369-376.